Related Experiment Video

Updated: Jul 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The use of statins in pediatrics: knowledge base, limitations, and future directions

Brook Belay1, Peter F Belamarich, Catherine Tom-Revzon

  • 1Department of Pediatrics, Temple University Children's Medical Center, 3509 N Broad St, Philadelphia, PA 19140, USA. brook.belay@tuhs.temple.edu

Pediatrics
|February 3, 2007
PubMed

Insights

Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) effectively prevent heart disease in adults. This review explores their use, benefits, and limitations in children, suggesting future applications for high-risk youth.

Area of Science:

  • Cardiology
  • Pharmacology
  • Pediatrics

Background:

  • Statins are widely used in adults to reduce cardiovascular morbidity and mortality.
  • Pediatric use of statins is currently limited.
  • Understanding the cholesterol hypothesis is key to statin application.

Purpose of the Study:

  • To review the established knowledge of statin use in adults and children.
  • To examine the efficacy of statins in primary and secondary cardiovascular event prevention.
  • To discuss statin toxicities and pediatric limitations.

Main Methods:

  • Literature review focusing on statin efficacy and safety.
  • Analysis of statin use in adult and pediatric populations.
  • Evaluation of statins in conjunction with noninvasive atherosclerosis assessment.

Main Results:

  • Statins are proven effective in reducing cardiovascular events in high-risk adults.
  • Current pediatric data on statin efficacy and safety is less extensive.
  • Noninvasive imaging can aid in assessing atherosclerotic burden.

Conclusions:

  • Further research is needed to optimize statin use in children.
  • Targeted statin therapy may benefit high-risk pediatric populations.
  • Advancing pediatric statin use requires careful consideration of benefits and risks.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...